Health care stocks were rising pre-bell Friday, with The Health Care Select Sector SPDR Fund (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) up 0.7%.
Novo Nordisk (NVO) will reduce the current year bonuses for employees eligible for short-term incentives in Denmark due to slower growth and a lowered forecast, Bloomberg News reported, citing a company spokesperson. The company's shares were up more than 2% premarket.
Keros Therapeutics' (KROS) largest stockholder, ADAR1 Capital Management, said it would like to "work collaboratively" with the board on strategy, capital allocation and potential board changes to unlock value for all shareholders. Keros Therapeutics stock was more than 1% higher pre-bell.
Ionis Pharmaceuticals (IONS) shares were 1% higher after the company said the US Food and Drug Administration approved Dawnzera as the first and only RNA-targeted prophylactic treatment for preventing attacks of hereditary angioedema in adults and pediatric patients 12 years of age and older.
精彩评论